Portfolio Grader currently ranks Regeneron Pharmaceuticals Inc (NASDAQ:REGN) a Hold. The methods for investing incorporated in this analytical tool developed by Louis Navellier evaluates and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. This represents no change from the previous week and is the same ranking REGN has had from Portfolio Grader for 6 months. More
HP Laptops May Reportedly Have Hidden Keylogger
HP laptops reportedly have a hidden keylogger that could be a privacy concern for owners of one of these 460 different HP computer models. More
High-Level Quant Score Keep Cellect Biotechnology (APOP) a Buy
With a $42.0 billion market value, Cellect Biotechnology Ltd (NULL:APOP) ranks in the top decile in its industry group, Biotechnology, and in the top 10% of its sector group, Health Care, in market value. From the viewpoint of investment attractiveness, the stock's Portfolio Grader ranking places it 46 among the 350 companies in this industry group, putting in the top quartile; in the top quartile of the sector with a ranking of 116 among the 782 companies in the sector, and number 670 in the nearly 5,000 company Portfolio Grader universe. More
Shire (SHPG) a Sell on Sagging Quant Score
Currently, Shire plc (NASDAQ:SHPG) has a Sell using Louis Navellier's investing methodology and his Portfolio Grader stock evaluator. SHPG has maintained this ranking for 11 months. More
Why American Express Purchases Won’t Require Your Signature Any More
American Express (AXP) is following Discover as it won't require signatures when you buy items with its credit cards starting on April 2018. More
Vapid Sales Growth Penalize Biogen (BIIB) Rating
Currently, Biogen Inc (NASDAQ:BIIB) has a Hold using Louis Navellier's methodology for investing and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 3 months. More
